Aurora Cannabis Inc.
NASDAQ:ACBDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $289.28M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.92M
Average 1.00M
ACB Interest Income
Income earned on cash, deposits, and investments held by the company.
Aurora Cannabis Inc.NASDAQ: ACB
Interest Income · Q4 FY2026 · quarter ended Mar 2026
Interest income declines year over year
Q4 FY2026 interest income of CA$1.04M fell 59.7% year over year, behind the -42.6% change in trailing-twelve-month interest income. Sequentially, it rose 5.3% from the prior quarter. Over 3 fiscal years it compounded at -32.4% a year.
Context
- Interest income amounted to 1.8% of revenue in FY2026, down 1.5 pp from a year earlier.
- Interest income increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -59.7% toward the trailing-twelve-month pace of -42.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Income history
CAD · from the income statement
- Latest · FY2026
- 5.86M CAD
- Year-over-year change
- -49.0%
- 4-year CAGR
- +6.8%
| Period | Period end | Interest Income | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 5.86M | -49.0% |
| FY2025 | 2025-03-31 | 11.51M | -10.2% |
| FY2024 | 2024-03-31 | 12.81M | -32.6% |
| FY2023 | 2023-03-31 | 19M | +321.6% |
| FY2022 | 2022-06-30 | 4.51M | — |
Interest Income vs competitors
How ACB compares with its peers on the latest reported figures
- Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -42.6% is the 5th highest of 6, against a peer median of +4.9%.
- Interest income amounts to 2.1% of revenue for ACB, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BIOABioAge Labs, Inc. | LTM Mar 2026 | $12.64M USD | +4.9% | +204.2% | 122.5% |
| LTM Mar 2026 | CA$11.15M CAD | +26.5% | -25.6% | 3.6% | |
| LTM Mar 2026 | $6.99M USD | -14.1% | — | 83.5% | |
| LTM Mar 2026 | CA$6.6M CAD | -42.6% | -32.4% | 2.1% | |
| LTM Mar 2026 | $4.91M USD | +17.7% | -24.6% | 1.4% | |
| LTM Mar 2026 | CA$459.35K CAD | — | — | 0.2% | |
| LTM Mar 2026 | $401K USD | — | — | 0.3% | |
| LTM Mar 2026 | $80.56K USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Apr 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Mar 2026 | -$1.51M USD | -112.9% | +14.6% | 3.9% | |
| Peer median (excluding ACB) | — | +4.9% | -5.0% | 0.8% | |
Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 221.34M | 223.8M | 270.28M | 343.29M | 321.42M |
| Cost of Revenue | 200.11M | 209.02M | 138.82M | 155.69M | 304.67M |
| Gross Profit | 21.23M | 14.78M | 131.46M | 187.61M | 16.75M |
| Gross Margin | 9.6% | 6.6% | 48.6% | 54.6% | 5.2% |
| Research & Development | 10.39M | 5.77M | 3.57M | 3.68M | 6.01M |
| Selling, General & Admin | 188.99M | 170.48M | 156.88M | 166.47M | 173.95M |
| Operating Expenses | 252.67M | 221.98M | 177.91M | 182.66M | 179.96M |
| Depreciation & Amortization | 93.66M | 52.59M | 33.07M | 22.55M | 14.23M |
| EBITDA | (1.55B) | (135M) | (12.34M) | 51.35M | (148.99M) |
| EBITDA Margin | -702.4% | -60.3% | -4.6% | 15.0% | -46.4% |
| Operating Income | (231.45M) | (207.19M) | (46.45M) | 4.95M | (163.21M) |
| Operating Margin | -104.6% | -92.6% | -17.2% | 1.4% | -50.8% |
| Interest Income | 4.51M | 19M | 12.81M | 11.51M | 5.86M |
| Interest Expense | 71.81M | 39.46M | 14.19M | 8.42M | 1.81M |
| Other Income / Expenses | (1.49B) | (576.51M) | (13.15M) | 15.43M | 106.54M |
| Income Before Tax | (1.72B) | (783.7M) | (59.6M) | 20.38M | (56.67M) |
| Pre-Tax Margin | -777.1% | -350.2% | -22.1% | 5.9% | -17.6% |
| Income Tax Expense | (2.14M) | 16.55M | (554K) | 4.62M | 2.1M |
| Net Income | (1.72B) | (816.63M) | (69.33M) | 1.59M | (122.07M) |
| Net Margin | -776.0% | -364.9% | -25.6% | 0.5% | -38.0% |
| EPS (Basic) | (79.92) | (8.17) | (1.28) | 0.03 | (2.15) |
| EPS (Diluted) | (79.92) | (8.17) | (1.28) | 0.03 | (2.15) |
| Weighted Avg Shares | 21.49M | 32.27M | 51.26M | 54.88M | 56.71M |
| Weighted Avg Shares (Diluted) | 21.49M | 32.27M | 51.26M | 55.75M | 56.71M |
Aurora Cannabis Inc.
NASDAQ:ACB
Intrinsic Alpha fair value
Locked
Current Price
$4.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.